Evidence map›Paper›PMID 27572395›Full record

ArticleAntimicrobial agents and chemotherapy2016

Prevalence of Quinolone Resistance in Enterobacteriaceae from Sierra Leone and the Detection of qnrB Pseudogenes and Modified LexA Binding Sites.

Tomasz A Leski, Michael G Stockelman, Umaru Bangura, Daniel Chae, Rashid Ansumana, David A Stenger, Gary J Vora, Chris R Taitt

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. In Vitro Susceptibility and Florfenicol Resistance inInternational journal of genomics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomasz A LeskiCenter for Bio/Medical Science and Engineering, Naval Research Laboratory, Washington, DC, USA tomasz.leski@nrl.navy.mil.ORCID 0000-0001-7688-9887
Michael G StockelmanCenter for Bio/Medical Science and Engineering, Naval Research Laboratory, Washington, DC, USA.
Umaru BanguraMercy Hospital Research Laboratory, Bo, Sierra Leone.
Daniel ChaeThomas Jefferson High School for Science and Technology, Alexandria, Virginia, USA.
Rashid AnsumanaMercy Hospital Research Laboratory, Bo, Sierra Leone.
David A StengerCenter for Bio/Medical Science and Engineering, Naval Research Laboratory, Washington, DC, USA.
Gary J VoraCenter for Bio/Medical Science and Engineering, Naval Research Laboratory, Washington, DC, USA.
Chris R TaittCenter for Bio/Medical Science and Engineering, Naval Research Laboratory, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A collection of 74 Enterobacteriaceae isolates found in Bo, Sierra Leone, were tested for quinolone antibiotic susceptibility and resistance mechanisms. The majority of isolates (62%) were resistant to quinolones, and 61% harbored chromosomal gyrA and/or parC mutations. Plasmid-mediated quinolone resistance genes were ubiquitous, with qnrB and aac(6')-Ib-cr being the most prevalent. Mutated LexA binding sites were found in all qnrB1 genes, and truncated qnrB pseudogenes were found in the majority of Citrobacter isolates.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBinding SitesDNA GyraseDNA Topoisomerase IVDrug Resistance, BacterialEnterobacteriaceaeEnterobacteriaceae InfectionsHumansLexA Repressor ProteinMicrobial Sensitivity TestsMutationPseudogenesQuinolonesSerine EndopeptidasesSierra LeoneAnti-Bacterial AgentsBacterial ProteinsDNA GyraseDNA Topoisomerase IVLexA Repressor ProteinQuinolonesSerine Endopeptidases

Identifiers

PMID27572395
PMCPMC5075108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.